Biliary Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-10-31
Clinical Trial Update: A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial update evaluating safety and efficacy of TQB2450 with Anlotinib in advanced biliary adenocarcinoma and hepatocellular carcino…